Position in APLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,816,100
+$2,210,666 QoQ
Shares Held
70,000
+579.6% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
1.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Derivatives in APLS
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
0
PutValue
$419,020
PutShares
7,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026HARVEST MANAGEMENT LLC holds $32,146,723 across 8 Biotechnology names. APLS ranks #5 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
257,500 | $13,575,400 | |
| 2 | ACLX |
Arcellx, Inc.
|
50,000 | $5,741,000 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
247,400 | $3,577,404 | |
| 4 | CNTA |
Centessa Pharmaceuticals plc
|
80,000 | $3,177,600 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
This page
|
70,000 | $2,816,100 | |
| 6 | DAWN |
Day One Biopharmaceuticals, Inc.
|
75,000 | $1,608,000 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
9,524 | $926,209 | |
| 8 | CYTK |
Cytokinetics Inc
|
11,000 | $725,010 |
All Filings in APLS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,816,100 | 70,000 | Shares | Other | 2026-05-15 | |
| 2024-03-31 | $605,434 | 10,300 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $419,020 | 7,000 | Put | Other | 2024-02-14 | |
| 2023-06-30 | $1,002,100 | 11,000 | Shares | Other | 2023-07-20 | |
| 2023-06-30 | $911,000 | 10,000 | Put | Other | 2023-07-20 | |
| No filing history on record for this holder in this stock. | ||||||